Prime Medicine, Inc. (PRME) vs Shattuck Labs, Inc. (STTK)

Prime Medicine, Inc. and Shattuck Labs, Inc. are both Biotechnology companies. Prime Medicine, Inc. and Shattuck Labs, Inc. are of similar size ($633.3M and $609.4M). Shattuck Labs, Inc. grew revenue faster over the last twelve months: 106.5% against −17.9%. Shattuck Labs, Inc. has the higher net margin (0.00% vs −4,613.1%) and the lower return on invested capital (−1,230.7% vs 0.00%). Across the 15 metrics below, Shattuck Labs, Inc. leads on 11 and Prime Medicine, Inc. on 4.

Valuation

Metric PRME STTK Biotechnology median
P/E n/m n/m 7.88
P/S 126.19 140.52 11.47
P/B 12.91 3.73 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 102.84 103.36 10.73
Earnings yield (37.01%) (8.40%) (28.84%)
Free cash flow yield (30.52%) (5.24%) (23.03%)

Profitability

Metric PRME STTK Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (4,824.94%) 0.00% 0.00%
Net margin (4,613.11%) 0.00% 0.00%
Free cash flow margin (3,850.92%) 0.00% 0.00%
Return on equity (373.29%) (39.21%) (57.72%)
Return on assets (71.16%) (36.88%) (49.22%)
Return on invested capital 0.00% (1,230.74%) 0.00%

Growth

Metric PRME STTK Biotechnology median
Revenue growth (TTM) (17.90%) 106.48% 5.64%
EPS growth (last fiscal year) 18.18% 53.02% —
Revenue growth, 5-year CAGR — (36.82%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRME STTK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.05 27.59 4.73
Net debt to EBITDA 0.88 1.62 0.96

Dividend

Metric PRME STTK Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric PRME STTK Biotechnology median
Market cap 609.43m 633.29m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack